| __timestamp | Sanofi | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 8565000000 | 305409000 |
| Thursday, January 1, 2015 | 9496000000 | 377080000 |
| Friday, January 1, 2016 | 9592000000 | 432829000 |
| Sunday, January 1, 2017 | 10164000000 | 496079000 |
| Monday, January 1, 2018 | 9934000000 | 557616000 |
| Tuesday, January 1, 2019 | 9883000000 | 658498000 |
| Wednesday, January 1, 2020 | 9390000000 | 770456000 |
| Friday, January 1, 2021 | 9555000000 | 840100000 |
| Saturday, January 1, 2022 | 10539000000 | 944700000 |
| Sunday, January 1, 2023 | 10765000000 | 1136600000 |
| Monday, January 1, 2024 | 9183000000 | 1464300000 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Sanofi and Vertex Pharmaceuticals have demonstrated contrasting approaches to SG&A cost management. From 2014 to 2023, Sanofi's SG&A expenses have consistently been higher, averaging around 9.8 billion annually, while Vertex Pharmaceuticals maintained a leaner structure with an average of 652 million. Despite Sanofi's larger scale, Vertex's ability to keep SG&A costs at approximately 7% of Sanofi's expenses highlights its efficiency. Notably, Vertex's SG&A expenses grew by 272% over the period, reflecting its rapid expansion and investment in growth. In contrast, Sanofi's expenses increased by 26%, indicating a more stable approach. This comparison underscores the strategic differences in cost management between a global giant and a nimble innovator in the pharmaceutical industry.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Sanofi vs Biogen Inc.
Comparing SG&A Expenses: Sanofi vs Opthea Limited Trends and Insights
Who Optimizes SG&A Costs Better? Sanofi or Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: Sanofi vs Amneal Pharmaceuticals, Inc.
Sanofi and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.